The impact of endovascular therapy on clinical, physiological and imaging parameters in patients with ilio-caval occlusive disease

Not Applicable

• Conditions: Ilio-caval venous occlusive disease; Cardiovascular - Other cardiovascular diseases; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12621001134819
• Lead Sponsor: Flinders Medical Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-08-23
• Study Completion: 2022-02-04
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

Patients with clinical signs and symptoms consistent with the presence of a non-thrombotic iliac vein lesion (NIVL) or post-thrombotic syndrome (PTS)
Clinical condition of sufficient severity that endovascular investigation with potential treatment using iliac venous stenting has been offered.

Exclusion Criteria

Patients who are unable to give informed consent due to language difficulties, or physical and/or mental incapacity
Patients under 18 years of age
Allergy to iodine based contrast media
Very short life expectancy (<6 months)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary patency of treated vein as determined by evidence of antegrade flow through the stented veins using a composite of duplex and colour Doppler ultrasound. Patency will be defined as evidence of flow through the treated vein with both duplex and colour Doppler[1, 6 and 12 months post procedure];Freedom from target vessel re-intervention determined by review of medical records[1, 6 and 12 months post procedure]